Interleukin-6, S-Nitrosothiols, and Neurodegeneration in Different Central Nervous System Demyelinating Disorders: Is There a Relationship?

about

Interleukin-6, S-Nitrosothiols, and Neurodegeneration in Different Central Nervous System Demyelinating Disorders: Is There a Relationship?

Item

http://www.wikidata.org/entity/Q55434832

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Interleukin-6, S-Nitrosothiols ...... ders: Is There a Relationship?

@en

Interleukin-6, S-Nitrosothiols ...... ders: Is There a Relationship?

@nl

type

Item

label

Interleukin-6, S-Nitrosothiols ...... ders: Is There a Relationship?

@en

Interleukin-6, S-Nitrosothiols ...... ders: Is There a Relationship?

@nl

prefLabel

Interleukin-6, S-Nitrosothiols ...... ders: Is There a Relationship?

@en

Interleukin-6, S-Nitrosothiols ...... ders: Is There a Relationship?

@nl

P1476

Interleukin-6, S-Nitrosothiols ...... ders: Is There a Relationship?

@en

P2093

Anna Vorobyeva

http://www.w3.org/2001/XMLSchema#string

Maria N Zakharova

http://www.w3.org/2001/XMLSchema#string

Mikhail V Onufriev

http://www.w3.org/2001/XMLSchema#string

Natalia V Gulyaeva

http://www.w3.org/2001/XMLSchema#string

Vera Fominykh

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

Diagnosis of multiple sclerosis: progress and challenges.

IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis.

Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.

Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.

Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases

Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study.

International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.

B cells in MS and NMO: pathogenesis and therapy.

P304

327-332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3988/JCN.2018.14.3.327

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lev Brylev

P577

2018-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29856157

http://www.w3.org/2001/XMLSchema#string

P932

6031979

http://www.w3.org/2001/XMLSchema#string